V. Melki

2.1k total citations
24 papers, 1.1k citations indexed

About

V. Melki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, V. Melki has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in V. Melki's work include Diabetes Management and Research (22 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (8 papers). V. Melki is often cited by papers focused on Diabetes Management and Research (22 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (8 papers). V. Melki collaborates with scholars based in France, Netherlands and Australia. V. Melki's co-authors include H Hanaire-Broutin, J. Tauber, Bogdan Catargi, Pierre‐Yves Benhamou, Jean‐Luc Bosson, P Schaepelynck-Bélicar, Éric Renard, Ravi Retnakaran, Bernard Zinman and Bruno Guerci and has published in prestigious journals such as PLoS ONE, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

V. Melki

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Melki France	15	914	488	396	223	55	24	1.1k
Cari Berget United States	20	1.1k 1.2×	664 1.4×	632 1.6×	158 0.7×	22 0.4×	55	1.2k
Federico Boscari Italy	15	578 0.6×	329 0.7×	299 0.8×	70 0.3×	38 0.7×	37	753
Dured Dardari France	12	498 0.5×	103 0.2×	92 0.2×	204 0.9×	51 0.9×	43	683
Torben Biester Germany	22	1.5k 1.6×	1.0k 2.1×	952 2.4×	67 0.3×	71 1.3×	77	1.7k
Gopika Krishnan India	13	377 0.4×	158 0.3×	142 0.4×	93 0.4×	25 0.5×	53	575
Ryan Paul New Zealand	12	332 0.4×	161 0.3×	173 0.4×	53 0.2×	21 0.4×	67	466
Georgia M. Davis United States	19	860 0.9×	235 0.5×	479 1.2×	57 0.3×	91 1.7×	55	1.1k
Carol J. Levy United States	20	866 0.9×	501 1.0×	436 1.1×	37 0.2×	34 0.6×	82	1.1k
D. Jane Holmes–Walker Australia	16	303 0.3×	243 0.5×	213 0.5×	40 0.2×	21 0.4×	34	576
Christina Dudley United Kingdom	5	204 0.2×	137 0.3×	144 0.4×	125 0.6×	13 0.2×	7	374

Countries citing papers authored by V. Melki

Since Specialization

Citations

This map shows the geographic impact of V. Melki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Melki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Melki more than expected).

Fields of papers citing papers by V. Melki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Melki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Melki. The network helps show where V. Melki may publish in the future.

Co-authorship network of co-authors of V. Melki

This figure shows the co-authorship network connecting the top 25 collaborators of V. Melki. A scholar is included among the top collaborators of V. Melki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Melki. V. Melki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amoura, Lamia, E. Sonnet, Sandrine Lablanche, et al.. (2023). MiniMed ^TM 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes. Diabetes Technology & Therapeutics. 25(12). 893–901. 13 indexed citations

Amadou, Coralie, V. Melki, Jean Pierre Allain, et al.. (2023). Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study. PLoS ONE. 18(8). e0289684–e0289684. 1 indexed citations

Guillaume, A., et al.. (2017). m-santé francophone et diabète : avancées en 2017. Médecine des Maladies Métaboliques. 11(6). 530–536.

Joubert, Michaël, S. Baillot-Rudoni, Bogdan Catargi, et al.. (2015). Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement. Diabetes & Metabolism. 41(6). 498–508. 14 indexed citations

Doron, Maéva, V. Melki, Sylvia Franc, et al.. (2014). Preliminary Evaluation of a New Semi-Closed-Loop Insulin Therapy System Over the Prandial Period in Adult Patients With Type 1 Diabetes. Journal of Diabetes Science and Technology. 8(6). 1177–1184. 18 indexed citations

Farret, Anne, Bogdan Catargi, V. Melki, et al.. (2012). 023 Étude randomisée contrôlée en cross-over comparant les effets sur le contrôle glycémique des bolus immédiats et combinés chez des patients diabétiques de type 1 traités par pompe à insuline portable. Diabetes & Metabolism. 38. A6–A6. 1 indexed citations

Liebl, Andreas, Roel P.L.M. Hoogma, Éric Renard, et al.. (2009). A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obesity and Metabolism. 11(11). 1001–1008. 53 indexed citations

Hanaire, H., et al.. (2009). Usefulness of Continuous Glucose Monitoring for the Diagnosis of Hypoglycemia after a Gastric Bypass in a Patient Previously Treated for Type 2 Diabetes. Obesity Surgery. 20(1). 126–129. 31 indexed citations

Jeandidier, N., Nadia Tubiana‐Rufi, A. Vambergue, et al.. (2008). Treatment of diabetes mellitus using an external insulin pump in clinical practice. Diabetes & Metabolism. 34(4). 425–438. 27 indexed citations

10.

Benhamou, Pierre‐Yves, V. Melki, R. Boizel, et al.. (2007). One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study. Diabetes & Metabolism. 33(3). 220–226. 98 indexed citations

11.

Renard, Éric, V. Melki, Bruno Guerci, et al.. (2006). Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study. Diabetes & Metabolism. 32(5). 427–432. 5 indexed citations

12.

Melki, V., et al.. (2006). Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. Diabetes & Metabolism. 32(2). 123–129. 25 indexed citations

13.

Guerci, Bruno, Nadia Tubiana‐Rufi, B. Bauduceau, et al.. (2005). Advantages to using capillary blood ɛ-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes & Metabolism. 31(4). 401–406. 56 indexed citations

14.

Melki, V., et al.. (2004). What are capillary blood ketone levels in type 1 diabetic patients using CSII in normal conditions of insulin delivery?. Diabetes & Metabolism. 30(6). 543–547. 6 indexed citations

15.

Retnakaran, Ravi, J. Hans DeVries, H Hanaire-Broutin, et al.. (2004). Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections. Diabetes Care. 27(11). 2590–2596. 158 indexed citations

16.

Gin, H., Éric Renard, V. Melki, et al.. (2003). Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. Diabetes & Metabolism. 29(6). 602–607. 50 indexed citations

17.

Catargi, Bogdan, Laurent Meyer, V. Melki, Éric Renard, & N. Jeandidier. (2002). Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.. PubMed. 28(2). 133–7. 28 indexed citations

18.

Hanaire-Broutin, H, et al.. (2000). Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens Using Insulin Lispro in Type 1 Diabetic Patients on Intensified Treatment. 22 indexed citations

19.

Hanaire-Broutin, H, et al.. (2000). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.. Diabetes Care. 23(9). 1232–1235. 137 indexed citations

20.

Melki, V., F Hullin, Honoré Mazarguil, et al.. (1994). Annexin I as a Potential Inhibitor of Insulin Receptor Protein Tyrosine Kinase. Biochemical and Biophysical Research Communications. 203(2). 813–819. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact